(Q63319730)

English

IL1-TRAP, Rilonacept, in Systemic Sclerosis

clinical trial

Statements

Randomized, Double-Blind, Placebo-Controlled Trial if IL1-TRAP, Rilonacept, in Systemic Sclerosis -A Phase I/II Biomarker Trial (English)
0 references
0 references
December 2011
0 references
January 2017
0 references
24
0 references
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit